MEDROXYPROGESTERONE 200mg/mL 50

Description

Please note that effective 09/01/17, the USEF will require medication report forms to be filed for horses treated with MPA (Medroxyprogesterone Acetate) if the horse had received treatment within three months of the competition start date.

The form can be found here.

To read more about the decision, please see the USEF’s announcement.